Hendriks LEL, Remon J, Faivre-Finn C, Garassino MC, Heymach JV, Kerr KM et al (2024) Non-small-cell lung cancer. Nat Rev Dis Primers 10(1):71

Article  PubMed  Google Scholar 

Zhao C, Zhang R, Yang H, Gao Y, Zou Y, Zhang X (2024) Antibody-drug conjugates for non-small cell lung cancer: advantages and challenges in clinical translation. Biochem Pharmacol 226:116378

Article  PubMed  CAS  Google Scholar 

Rajaram R, Huang Q, Li RZ, Chandran U, Zhang Y, Amos TB et al (2024) Recurrence-free survival in patients with surgically resected non-small cell lung cancer: A systematic literature review and meta-analysis. Chest 165(5):1260–1270

Article  PubMed  Google Scholar 

Petrella F, Rizzo S, Attili I, Passaro A, Zilli T, Martucci F et al (2023) Stage Iii non-small-cell lung cancer: an overview of treatment options. Curr Oncol 30(3):3160–3175

Article  PubMed  PubMed Central  Google Scholar 

Talib WH, Alsalahat I, Daoud S, Abutayeh RF, Mahmod AI (2020) Plant-derived natural products in cancer research: Extraction, mechanism of action, and drug formulation. Molecules 25(22):5319

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK et al (2020) Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol 177(6):1409–1423

Article  PubMed  CAS  Google Scholar 

Kretzing S, Abraham G, Seiwert B, Ungemach FR, Krugel U, Teichert J et al (2011) In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis. Arch Toxicol 85(12):1565–1573

Article  PubMed  CAS  Google Scholar 

Nair JJ, van Staden J (2014) Cytotoxicity studies of Lycorine alkaloids of the Amaryllidaceae. Nat Prod Commun 9(8):1193–1210

PubMed  CAS  Google Scholar 

Qi J, Meng M, Liu J, Song X, Chen Y, Liu Y et al (2023) Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing notch1 degradation and downregulating key vasculogenic genes. Biochem Pharmacol 217:115833

Article  PubMed  CAS  Google Scholar 

Yang C, Xiang H, Fu K, Jin L, Yuan F, Xue B et al (2022) Lycorine suppresses cell growth and invasion via down-regulation of nedd4 ligase in bladder cancer. Am J Cancer Res 12(10):4708–4720

PubMed  PubMed Central  CAS  Google Scholar 

Li L, Zhang Z, Yang Q, Ning M (2019) Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the mir-186/cdk1 axis. Life Sci 231:116528

Article  PubMed  CAS  Google Scholar 

Jiang ZB, Xu C, Xu P, Huang DH, Kang LP (2024) Lycorine suppresses non-small-cell lung cancer progression through activating Sting pathway and stimulating an antitumor immune response. Chem Biol Drug Des 104(6):e70036

Article  PubMed  CAS  Google Scholar 

Xia F, Yang H, Wu H, Zhao B (2024) Spindle component 25 predicts the prognosis and the immunotherapy response of cancers: A pan-cancer analysis. Sci Rep 14(1):8452

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liao LX, Zhang M, Xu X, Zhang S, Guo YZ (2024) Spc25 functions as a prognostic-related biomarker, and its high expression correlates with tumor immune infiltration and Ucec progression. Front Biosci (Landmark Ed) 29(2):69

Article  PubMed  Google Scholar 

Chen J, Chen H, Yang H, Dai H (2018) Spc25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival. Biomed Pharmacother 100:233–239

Article  PubMed  CAS  Google Scholar 

Lv M, Chen X, Yang Q, Huang C, Lv Y, Zhang T et al (2025) Berberine restrains non-small cell lung cancer cell growth, invasion and Glycolysis via inactivating the spc25/nuf2 pathway. Naunyn Schmiedebergs Arch Pharmacol 398(6):7439–7451

Article  PubMed  CAS  Google Scholar 

Shen H, Geng Z, Nie X, Liu T (2023) Erianin induces ferroptosis of renal cancer stem cells via promoting alox12/p53 Mrna n6-methyladenosine modification. J Cancer 14(3):367–378

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen N, Li P, Liu L, Zhang J, Cao Z, Chen Z et al (2023) Cucurbitacin Iib extracted from Hemsleya penxianensis induces cell cycle arrest and apoptosis in bladder cancer cells by regulating cell cycle checkpoints and mitochondrial apoptotic pathway. Plant Foods Hum Nutr 78(2):483–492

Article  PubMed  CAS  Google Scholar 

Xue Q, Wang B, Feng J, Li C, Yu M, Zhao Y et al (2024) Lycorine (lycoris radiata)-a unique natural medicine on breast cancer. J Cell Mol Med 28(16):e70032

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhuo FF, Li L, Liu TT, Liang XM, Yang Z, Zheng YZ et al (2025) Lycorine promotes idh1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells. Cancer Lett 614:217533

Article  PubMed  CAS  Google Scholar 

Zhai J, Jiang JF, Shi L (2023) Lycorine weakens Tamoxifen resistance of breast cancer via abrogating haglr-mediated epigenetic suppression on vgll4 by dnmt1. Kaohsiung J Med Sci 39(3):278–289

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sun Y, Wu P, Sun Y, Sharopov FS, Yang Q, Chen F et al (2018) Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking wnt/beta-catenin signaling and epithelial-mesenchymal transition (emt). Biochem Biophys Res Commun 495(1):911–921

Article  PubMed  CAS  Google Scholar 

Wang Q, Zhu Y, Li Z, Bu Q, Sun T, Wang H et al (2019) Up-regulation of spc25 promotes breast cancer. Aging 11(15):5689–5704

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang X, Yang M, Zhang W, Shi D, Li Y, He L et al (2024) Targeting the spc25/riok1/myh9 axis to overcome tumor stemness and platinum resistance in epithelial ovarian cancer. Adv Sci (Weinh) 11(47):e2406688

Article  PubMed  PubMed Central  Google Scholar 

Su M, Luo J, Chen W, Li X, Ye D, Zeng X et al (2024) Spc25 activates the Warburg effect to inhibit ferroptosis in prostate cancer cells. Am J Mens Health 18(6):15579883241297880

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Yu L, Xu C, Tang T, Cao J, Chen L et al (2024) Plek2 activates the pi3k/akt signaling pathway to drive lung adenocarcinoma progression by upregulating spc25. Cell Biol Int 48(9):1285–1300

Article  PubMed  CAS  Google Scholar 

Liu XS, Zhang Y, Ming X, Hu J, Chen XL, Wang YL et al (2024) Spc25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and Cerna in lung adenocarcinoma. Aging 16(1):779–798

PubMed  PubMed Central  CAS  Google Scholar 

Ye B, Yang G, Li Y, Zhang C, Wang Q, Yu G (2020) Znf143 in chromatin looping and gene regulation. Front Genet 11:338

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong Y, Hu M, Tan K, Dai R (2023) Znf143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased Lncrna neat1 expression to activate rock2 pathway. Epigenetics 18(1):2239592

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Li Q, Wei S, Sun J, Zhang X, He L et al (2020) Znf143 suppresses cell apoptosis and promotes proliferation in gastric cancer via ros/p53 axis. Dis Markers 2020:5863178

Article  PubMed  PubMed Central